Veterinary Medicine Information website

CENMICIN-LC (5+10)G/100ML, ενέσιμο διάλυμα

Authorised
  • Lincomycin
  • Spectinomycin
Download as PDF

Product identification

Medicine name:
CENMICIN-LC (5+10)G/100ML, ενέσιμο διάλυμα
Active substance:
  • Lincomycin
  • Spectinomycin
Target species:
  • Cattle
  • Pig
  • Sheep
  • Goat
  • Poultry
  • Dog
  • Cat
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Lincomycin
    50.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Spectinomycin
    100.00
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        14
        day
      • Milk
        2
        day
    • Pig
      • Meat and offal
        14
        day
    • Sheep
      • Meat and offal
        14
        day
      • Milk
        2
        day
    • Goat
      • Meat and offal
        14
        day
      • Milk
        2
        day
    • Poultry
      • Meat and offal
        14
        day
    • Dog
      • Meat and offal
        no withdrawal period
    • Cat
      • Meat and offal
        no withdrawal period
  • Subcutaneous use
    • Cattle
      • Meat and offal
        14
        day
      • Milk
        2
        day
    • Pig
      • Meat and offal
        14
        day
    • Sheep
      • Meat and offal
        14
        day
      • Milk
        2
        day
    • Goat
      • Meat and offal
        14
        day
      • Milk
        2
        day
    • Poultry
      • Meat and offal
        14
        day
    • Dog
      • Meat and offal
        no withdrawal period
    • Cat
      • Meat and offal
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01FF52
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Greece
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone)
Marketing authorisation holder:
  • A. Nikolakopoulos S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Cenavisa S.L.
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 21232/19-11-1992/K-0065001
Date of authorisation status change: